Search
Friday 7 August 2015
  • :
  • :

Active Stocks News Alert: Merck & Co., Inc. (NYSE:MRK), Rayonier Inc. (NYSE:RYN), Liberty Media Corp (NASDAQ:LMCA)

On Wednesday, Shares of Merck & Co., Inc. (NYSE:MRK), lost -1.09% to $57.36.

Merck & Co., declared results from a Phase 3 study investigating the safety and efficacy of single-dose EMEND (fosaprepitant dimeglumine) for Injection, Merck’s substance P/neurokinin (NK-1) receptor antagonist, in combination with other anti-vomiting medicines, for the prevention of chemotherapy-induced nausea and vomiting (CINV) in adult cancer patients receiving moderately emetogenic (vomit-inducing) chemotherapy (MEC). In the study, the first to evaluate an intravenous NK-1 receptor antagonist for the prevention of CINV associated with MEC, the single-dose EMEND for Injection regimen offered greater protection from nausea and vomiting following administration of chemotherapy as compared to an active control of placebo with other anti-vomiting medicines. These data were presented in an oral session at the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) Annual Meeting on Supportive Care in Cancer (Abstract #27-02-O) in Copenhagen (June 25-27, 2015).

“The results from this important Phase 3 trial are very encouraging as they are the first study to evaluate EMEND for Injection in a combination regimen for the prevention of chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy – and show the potential to use a single day antiemetic regimen,” said Dr. Bernardo L. Rapoport, principal investigator for the study and chief medical oncologist, Medical Oncology Centre of Rosebank, Johannesburg, South Africa.

Merck & Co., Inc. provides health care solutions worldwide. The company offer therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus, HIV-1 infection, fungal infections, intra-abdominal infections, hypertension, arthritis and pain, inflammatory, osteoporosis, male pattern hair loss, and fertility diseases.

Shares of Rayonier Inc. (NYSE:RYN), declined -0.27% to $26.28, during its last trading session.

Rayonier, declared the company has attained about 18,000 acres of high-quality timberlands in southwest Louisiana and northwest Oregon in two separate transactions from BTG Pactual Timberland Investment Group. Both properties are located near existing Rayonier landholdings:

  • The Louisiana property – known as the King parcel – comprises of about 12,200 acres of high quality, well managed southern pine timberland located in strong timber markets. The property was purchased for $25.5 million. It contains merchantable inventory of about 560,000 tons, is comprised of about 86% plantable lands, and is predictable to improve the company’s sustainable yield by about 45,000 tons per year. This acquisition expands Rayonier’s ownership in Louisiana to about 150,000 acres.
  • The Oregon property – known as the Scappoose parcel – comprises of about 5,600 acres of highly productive, well-stocked and highly-operable timberland tributary to strong domestic and export markets in the northwest corner of the state, near current company holdings in southwest Washington. The property was purchased for $34 million. It complements the age-class profile of the company’s Pacific Northwest timber holdings, contains merchantable inventory of about 102,000 tons (12.7 MMBF) of which an estimated 95% is high-value Douglas-fir, is comprised of about 88% operable lands, and is predictable to improve the company’s sustainable yield by about 35,000 tons (4.4 MMBF) per year. This acquisition expands Rayonier’s footprint into the state of Oregon and grows Rayonier’s total Pacific Northwest ownership to about 374,000 acres.

Rayonier Inc. operates as an investment arm of Rayonier TRS Operating Company. Rayonier, Inc. engages in the sale and development of real estate and timberland administration, in addition to in the production and sale of cellulose fibers in the United States, New Zealand, and Australia.

Finally, Liberty Media Corp (NASDAQ:LMCA), ended its last trade with -2.67% loss, and closed at $34.98.

Liberty Media Corporation’s, will host a conference call to talk about results for the second quarter of 2015 on Wednesday, August 5th, at 11:30 a.m. (E.D.T.). Following prepared remarks, the company will host a brief Q&A session during which administration will accept questions regarding both Liberty Media Corporation and Liberty Broadband Corporation. During the call, Mr. Maffei may talk about the financial performance and outlook of both companies, in addition to other forward looking matters.

Liberty Media Corporation, through its auxiliaries, engages in the media, communications, and entertainment businesses primarily in North America. The company broadcasts music, sports, entertainment, comedy, talk, news, traffic, and weather channels, in addition to infotainment services on a subscription fee basis through its satellite radio systems; provides connected vehicle applications and services to enhance the safety, security, and driving experience for vehicle operators; streams music and non-music channels over the Internet; and distributes satellite and Internet radios, and accessories primarily through automakers, retail stores, and Website.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.




Leave a Reply

Your email address will not be published. Required fields are marked *